$38.00
-7.5-16.48%
Last update: Apr 26, 8:29 AM
15 minutes delayed
Belite Bio
BLTENASDAQ
Belite Bio (NASDAQ:BLTE) Stock, Analyst Ratings, Price Targets, Predictions
Belite Bio Inc has a consensus price target of $40.2, established from looking at the 25 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Benchmark, and HC Wainwright & Co. on June 13, 2024, May 16, 2024, and May 15, 2024. With an average price target of $58.33 between HC Wainwright & Co., Benchmark, and HC Wainwright & Co., there's an implied 53.51% upside for Belite Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
HC Wainwright & Co.
Benchmark
Maxim Group
SVB Leerink
1calculated from analyst ratings
Analyst Ratings for Belite Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim | — | Reiterates | → Overweight | Get Alert |
| 06/13/2024 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim | — | Reiterates | → Overweight | Get Alert |
| 03/22/2024 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | $59 → $59 | Maintains | Buy | Get Alert |
| 03/13/2024 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2023 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/14/2023 | Buy Now | 57.89% | Maxim Group | Jason McCarthy | → $60 | Initiates | → Buy | Get Alert |
| 11/15/2023 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | → $59 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2023 | Buy Now | 55.26% | HC Wainwright & Co. | Yi Chen | $55 → $59 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 44.74% | HC Wainwright & Co. | Yi Chen | → $55 | Reiterates | Buy → Buy | Get Alert |
| 07/28/2023 | Buy Now | 13.16% | Cantor Fitzgerald | Jennifer Kim | → $43 | Initiates | → Overweight | Get Alert |
| 07/26/2023 | Buy Now | -34.21% | SVB Leerink | Marc Goodman | → $25 | Initiates | → Outperform | Get Alert |
| 07/25/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 07/25/2023 | Buy Now | 44.74% | HC Wainwright & Co. | Yi Chen | → $55 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 44.74% | HC Wainwright & Co. | Yi Chen | $58 → $55 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 02/22/2023 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 02/21/2023 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Reiterates | → Buy | Get Alert |
| 08/01/2022 | Buy Now | 52.63% | HC Wainwright & Co. | Yi Chen | → $58 | Initiates | → Buy | Get Alert |
| 07/01/2022 | Buy Now | 50% | Benchmark | Bruce Jackson | → $57 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Belite Bio (BLTE) stock?
The latest price target for Belite Bio (NASDAQ:BLTE) was reported by Cantor Fitzgerald on June 20, 2024. The analyst firm set a price target for $0.00 expecting BLTE to fall to within 12 months (a possible -100.00% downside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Belite Bio (BLTE)?
The latest analyst rating for Belite Bio (NASDAQ:BLTE) was provided by Cantor Fitzgerald, and Belite Bio reiterated their overweight rating.
When was the last upgrade for Belite Bio (BLTE)?
There is no last upgrade for Belite Bio
When was the last downgrade for Belite Bio (BLTE)?
There is no last downgrade for Belite Bio.
When is the next analyst rating going to be posted or updated for Belite Bio (BLTE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Belite Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Belite Bio was filed on June 20, 2024 so you should expect the next rating to be made available sometime around June 20, 2025.
Is the Analyst Rating Belite Bio (BLTE) correct?
While ratings are subjective and will change, the latest Belite Bio (BLTE) rating was a reiterated with a price target of $0.00 to $0.00. The current price Belite Bio (BLTE) is trading at is $38.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.